|Home | About | Journals | Submit | Contact Us | Français|
Inhibitors of the Wingless-related Integration site (WNT)/β-catenin pathway have recently been under consideration as potential chemopreventive agents against Familial Adenomatous Polyposis (FAP). This autosomal-dominant syndrome is caused by germline mutations in the gene coding for the protein APC and leads to hyperactivation of the WNT/β-catenin signaling pathway, uncontrolled intestinal cell proliferation and formation of adenocarcinomas. The aim of the present work was to: (i) test, on in vitro cultures of cells carrying FAP mutations and on ex vivo biopsies of FAP patients, the WNT inhibitory activity of extracts from two common southern Italian apples, Malus pumila Miller cv. ‘Annurca’ and Malus domestica cv ‘Limoncella’; (ii) identify the mechanisms underpinning their activities and; (iii) evaluate their potency upon gastrointestinal digestion. We here show that both Annurca and Limoncella apple extracts act as WNT inhibitors, mostly thanks to their polyphenolic contents. They inhibit the pathway in colon cells carrying FAP mutations with active dilutions falling in ranges close to consumer-relevant concentrations. Food-grade manufacturing of apple extracts increases their WNT inhibitory activity as result of the conversion of quercetin glycosides into the aglycone quercetin, a potent WNT inhibitor absent in the fresh fruit extract. However, in vitro simulated gastrointestinal digestion severely affected WNT inhibitory activity of apple extracts, as result of a loss of polyphenols. In conclusion, our results show that apple extracts inhibit the WNT pathway in colon cells carrying FAP mutations and represent a potential nutraceutical alternative for the treatment of this pathology. Enteric coating is advisable to preserve the activity of the extracts in the colon-rectal section of the digestive tract.
Familial adenomatous polyposis (FAP) is an inherited gastrointestinal syndrome, characterized by the formation of a large number of adenomas throughout the small intestine and the large bowel. FAP has a birth incidence of about 1/8300, manifests equally in both sexes, and accounts for less than 1% of colorectal cancer (CRC) cases . The birth frequency of FAP patients in European populations is estimated at roughly 1 in 11,300–37,600 live births and its progression to colorectal cancer is close to 100% by the age of 35–40 years . While colectomy remains the optimal prophylactic treatment, the identification of chemopreventive agents represents one of the major challenges for the future .
FAP is caused by a germline mutation in the Adenomatous Polyposis Coli (APC) gene on chromosome 5q21–q22. This locus contains a tumor suppressor gene encoding for the protein APC, that functions intracellularly as a scaffold in a large protein complex, known as “β-catenin destruction complex” . This includes the serine/threonine kinase, glycogen synthase kinase-3 β (GSK-3β), Axin, and casein kinase I . The complex represents an important intracellular checkpoint. In virtue of its ability to target β-catenin for proteasomal degradation, it reduces its intracellular levels. This activity avoids β-catenin translocation into the nucleus, binding to the transcription factors, TCF and LEF, and induction of oncogenes, like c-myc and cyclin D1 [5,6].
In wild type cells, APC counterbalances the activity of the Wingless-related Integration site (WNT) pathway, a signaling cascade regulating development in embryos and tissue homeostasis in adult organs. In the gastrointestinal (GI) tract, WNT supports the self-renewal capacity of epithelial stem cells and allows GI organs to be the most intensively self-replenishing in mammals . The class F G-Protein-Coupled Receptor (GPCR) family members, Frizzleds (FZDs), act as a WNT receptors. Upon activation, these recruit and disassemble the β-catenin destruction complex, inhibiting its function and causing β-catenin intracellular accumulation and nuclear translocation . This is the reason for why FAP mutations, by abolishing APC function, lead to constitutively active WNT signaling and, in turn, to uncontrolled proliferation of colon cells, formation of polyps and adenocarcinomas .
Apple extracts have been shown to mediate several biological cellular effects that might be of interest with respect to chemoprevention of colorectal diseases [9,10,11,12]. Such activity mostly relies on the high number of polyphenols they contain [13,14,15]. Polyphenol-rich apple extracts have been shown to suppress human colon cancer cell growth in several in vitro culture models [16,17,18]. Moreover, in APCMin/+ mice (a murine model of FAP), the consumption of beverages containing apple polyphenol extracts has been shown to affect the number and growth of colon polyps and reduce colorectal bleeding and high-grade dysplasia . So far, the biological activity of apple polyphenols has been mainly ascribed to their antioxidant potential . However, the exact mechanisms underpinning WNT’s inhibitory activity of apple extract is not yet clear. Recently, several polyphenols have been proposed of being endowed with modulatory activities toward specific protein targets; this includes, among others, many of the components WNT signaling pathway [11,14,21].
The aim of the present work was to test the WNT inhibitory activity of two apple cultivars, native to Southern Italy, namely “Annurca” and “Limoncella”, identify the polyphenols mainly responsible for their inhibitory activity and determine their mechanism of action.
Malus pumila Miller cv. Annurca is a widespread apple and accounts for 5% of Italian apple production. It is listed as a Protected Geographical Indication (PGI) product from the European Council (Commission Regulation (EC) No. 417/2006)). This apple has been already shown to possess nutraceutical potential in virtue of its ability to reduce cellular glucose levels and lipid uptake [22,23,24,25]. Malus domestica cv ‘Limoncella’ is a juicy and aromatic variety of apple, known since ancient Roman times . It is resistant to long time storage and can survive cold winters. In contrast to Annurca, Limoncella’s nutraceutical potential has not yet been documented .
In the current study, we tested, on in vitro cultures of cells carrying FAP mutations and on ex vivo biopsies of FAP patients, the WNT inhibitory activity of Annurca and Limoncella apple extracts, aimed to identify the mechanism underpinning their activity and evaluate their potency upon in vitro simulated GI digestion.
Chemicals and reagents used were either analytical-reagent or HPLC grade. The water was treated in a Milli-Q water purification system (Millipore, Bedford, MA, USA) before use. The standards used for the identification and quantification of phenolic acids and flavonoids were chlorogenic acid, (+)-catechin, (−)-epicatechin, phloretin, phloridzin, procyanidin B2, quercetin, rutin (quercetin-3-O-rutinoside) and isoquercetin (quercetin-3-O-glucoside), (Sigma Chemical Co., St. Louis, MO, USA). Chemicals and reagents used to simulate the GI digestion were potassium chloride (KCl), potassium thiocyanate (KSCN), monosodium phosphate (NaH2PO4), sodium sulphate (Na2SO4), sodium chloride (NaCl), sodium bicarbonate (NaHCO3), urea, α-amylase, hydrochloric acid (HCl), pepsin, pancreatin and bile salts (Sigma Chemical Co., St. Louis, MO, USA). Acetonitrile and methyl alcohol were of HPLC grade (Carlo Erba, Milano, Italy). The Nuclear Factor of Activated T-cells (NFAT) inhibitor, cell permeable (sequence: RRRRRRRRRRRGG GMAGPHPVIVITGPHEE; #592517-80-1, Tocris, Bristol, UK) was dissolved in water; Bisindolymaleimide II (3-(1H-Indol-3-yl)-4-[1-[2-(1-methyl-2-pyrrolidinyl)ethyl]-1H-indol-3-yl]-1H-pyrrole-2,5-dione, #137592-45-1, Tocris, Bristol, UK) was dissolved in DMSO.
Annurca (Malus Pumila Miller cv Annurca) apple fruits and Limoncella (Malus Domestica cv Limoncella) were collected from Valle di Maddaloni (Caserta, Italy), in October 2016, when fruits had just been harvested. Annurca fruits were reddened for about 30 days , and then analyzed. Lyophilised peels and flesh (10 g) of Limoncella and Annurca apple samples were treated with 60 mL of 80% methanol (0.5% formic acid), homogenized for 5 min by ultra-turrax (T25-digital, IKA, Staufen im Breisgau, Berlin, Germany) and shaken on an orbital shaker (Sko-DXL, Argolab, Carpy, Italy) at 300 rpm for 15 min. Then, the samples were placed in an ultrasonic bath for another 10 min, before being centrifuged at 6000 rpm for 10 min. The supernatants were collected and stored in darkness, at 4 °C. The pellets obtained were re-extracted, as described above and with another 40 mL of the same mixture of solvents. Finally, the extracts obtained were filtered under vacuum, the methanol fraction was eliminated by evaporation, and the water fraction was lyophilized. To obtain polyphenol-enriched fractions of Annurca apple extract (AAE) and Limoncella apple extract (LAE) (in the text referred to as PEF(AAE) and PEF(LAE), respectively) the dry extracts were dissolved in distilled water and slowly filtered through an Amberlite XAD-2 column, packed as follows: Resin (10 g; pore size 9 nm with particle sizes of 0.3–1.2 mm; Supelco, Bellefonte, PA, USA) was soaked in methanol, stirred for 10 min and then packed into a glass column (10 × 2 cm). The column was washed with 100 mL of acidified water (pH 2) and 50 mL of deionized water for removal of sugars and other polar compounds. The adsorbed phenolic compounds were extracted from the resin by elution with 100 mL of methanol, which was evaporated by flushing with nitrogen. The extracts were stored at −80 °C until HPLC analysis. Before performing the biological tests, each extract was dissolved in DMSO at a final concentration of 300 mg/mL. Food grade Limoncella apple extracts (IndLAE) were produced at MB-Med (Turin, Italy) starting from fresh Limoncella Apples. Upon lyophilization of peels and flesh of Limoncella apples, samples were treated with ethanol/water (70:30 v/v) for 24 h at 40 °C to extract phenolic compounds and generate food grade Limoncella Apple Extracts (in the text referred to as IndLAE).
The assay was performed according to the procedure described by Raiola et al.  and by Tenore et al. , with few modifications. For GI digestion, the apple samples (20 g) were mixed with 6 mL of artificial saliva composed of KCl (89.6 g/L), KSCN (20 g/L), NaH2PO4 (88.8 g/L), Na2SO4 (57.0 g/L), NaCl (175.3 g/L), NaHCO3 (84.7 g/L), urea (25.0 g/L) and 290 mg of α-amylase. The pH of the solution was adjusted to 6.8 with HCl 0.1 N. The mixture was introduced in a plastic bag containing 40 mL of water and homogenized in a Stomacher 80 Microbiomaster (Seward, Worthing, UK) for 3 min. Immediately, 0.5 g of pepsin (14,800 U) dissolved in HCl 0.1 N was added, the pH was adjusted to 2.0 with HCl 6 N, and the solution was incubated at 37 °C in a Polymax 1040 orbital shaker (250 rpm) (Heidolph, Schwabach, Germany) for 2 h. Then the pH was increased to 6.5 with NaHCO3 0.5 N and 5 mL of a mixture of pancreatin (8.0 mg/mL) and bile salts (50.0 mg/ mL) (1:1; v/v), dissolved in 20 mL of water, was added and incubated at 37 °C in an orbital shaker (250 rpm) for 2 h. Supernatants were extracted with an acetonitrile/water (84:16; v/v) mixture, and then either analyzed by HPLC or dried and dissolved in DMSO for biological tests.
HPLC separation and quantification of phenolic compounds in apple extracts and samples obtained from in vitro digestion, were performed according to earlier studies  with some modifications. Identification was possible by comparing spectra and retention times with those of commercial standards and with those reported in previous works . The column selected was a Hypersil BDS C18 column (250 mm, 4.6 mm, 5 μm) (Thermo, Bellefonte, PA, USA). Analyses were run on a Finnigan HPLC system (Thermo Electron Corporation, San Jose, CA, USA) provided with a photodiode array detector (DAD). The identity of phenolic acids and flavonoids was confirmed with LC-ESI/MS/MS experiments, as already reported .
HEK293, CaCo-2, and U87MG cells were grown in DMEM (#41965-039, GIBCO, Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% FBS (#10270, GIBCO), Glutamax (#35050-061, GIBCO) and Pen/Strep (#15070-063, GIBCO). HEK293 transfection was performed using Polyethylenimine ( Sigma Chemical Co., St. Louis, MO, USA). CaCo-2 transfection was performed using Lipofectamine (Thermo Fisher Scientific, Waltham, MA, USA) following the manufacturer’s instructions. Both cell cultures and human biopsies were analyzed for viability using Trypan blue, Propidium Iodide (PI) and Acridine-Orange (AO) staining. A pre-mixed AO/PI solution was directly added to cell samples for viability analysis, using a fluorescent cell counter.
Biopsies from Familial Adenomatosis Poliposis patients were kindly provided by Prof. G.B. Rossi. The study was approved by the Ethics Committee of the University Federico II of Naples. For all the patients enrolled in this study, polypectomy was part of their clinical treatment plan and it was scheduled and performed independently from this research. Immediately after excision, biopsies were rinsed in physiological saline. Samples were then digested with Trypsin for 10 min at room temperature (RT) and centrifuged at 400 rpm for 10 min at RT. Isolated cells were then counted and cultured at the confluency of 100,000 cell per mL in DMEM, supplemented with 10% FBS, Glutamax and Pen/Strep. When indicated, apple extracts were added at a concentration of 400 mg/L. After 24 and 48 h of incubation, cell viability was measured with using Trypan blue, Propidium Iodide (PI) and Acridine-Orange (AO) staining.
All DNA constructs were synthesized at GeneScript (Piscataway, NJ, USA). The cDNA coding for N terminally HA tagged FZD4wt (HA-FZD4-wt), was cloned in the expression vector, pCDNA3.1 (Invitrogen). For the reporter construct, WNT reporter Green Fluorescent Protein GFP construct (TCF-wt GFP), 8 repeats of the optimized TCF/LEF binding sequence [5′-AGATCAAAGGGG-3′] (interspaced by the triplet 5′-GTA-3′) were positioned upstream to a minimal TATA box promoter [5′-tagagggtatataatggaagctcgaattccag-3′] and a KOZAC region [5′-cttggcattccggtactgttggtaaaaagcttggcattccggtactgttggtaaagccacc-3′]. The sequence was cloned in the vector pCDNA 3.1 (+) GFP between the restriction sites for NruI and HindIII. This replacement substitutes the cytomegalovirus (cmv) promoter of the original vector with the TCF/LEF responsive sequences. The correctness of the sequences were verified by DNA sequencing. The reporter construct (TCF-mut GFP) was used as a negative control. This was obtained by the mutagenesis of TCF-wt GFP and presented the 8 repeats of the TCF/LEF binding sequence mutated to [5′-AGGCCAAAGGGG-3′]. The reporter construct, cmv GFP, used in this manuscript as the transfection control, was obtained by replacing the TCF/LEF consensus region in TCF-wt GFP with a cmv promoter.
HEK293 cells were seeded (5 × 103 per well) in 96-well black Optyplates (Perkin Elmer, Waltham, MA, USA). After 24 h, cells were co-transfected with both WNT reporter GFP construct and HA-FZD4-wt. Transfection mixtures were prepared as follows: for each well, 0.25 µg of PEI (pH 7.0) was supplemented with 0.08 µg of DNA (both diluted in 4 μL of DMEM). The mixture was incubated at room temperature (RT) for 30 min, to be then diluted in culture medium and added to the cells. Twenty-four hours after transfection, the medium was replaced and cells were incubated with WNT5A conditioned medium. Human glyoblastoma U87MG cells were used as a source of WNT5A conditioned medium . U87MG cells endogenously express FZD4, which has been shown to be necessary for the activity of WNT/β-catenin pathway in these cells . Confluent 6 cm plates of U87MG cells were incubated for 3 days in DMEM, 10% FBS and Glutamax, in the absence of antibiotics. Conditioned medium was subsequently collected and stored at −20 °C. Cells were then rinsed with fresh medium and cultivated for a further period of 3 days. The conditioned medium obtained after the second incubation was pooled with the first one. The pooled conditioned medium was used to stimulate TCF/LEF activity in HEK293 cells. It was used undiluted. When required, the conditioned medium was supplemented with apple extracts at the indicated concentrations. When reported, cells were supplemented with LiCl, Epidermal Growth Factor (EGF), NFAT inhibitor (10 µM) or Bisindolylmaleimide II (7.5 µM). After 48 h, cells were fixed in 3.7% formaldehyde, in PBS (pH 7.4), for 30 min. Formaldehyde was quenched by incubating the cells for 30 min in 0.1 M glycine in PBS 1x. The activity of the apple extract was evaluated by measuring GFP expression.
CaCo-2 cells, growing on glass coverslips, were transfected by Lipofectamine , according to the to the manufacturer’s procedures. Twenty-four hours after transfection, the medium was replaced and cells were incubated with the indicated extracts for 24–48 h. The cells were then fixed in a solution of 3.7% formaldehyde, in PBS with a pH 7.4, for 30 min. Formaldehyde was quenched by incubating the cells for 30 min in 0.1 M glycine in PBS.
CaCo-2 cells were grown on glass coverslips. Cells were fixed in 3.7% formaldehyde/PBS (pH 7.4) for 30 min. Formaldehyde was quenched by incubating the cells for 30 min in 0.1 M glycine in PBS 1x. Then, cells were permeabilized in 0.1% Triton/PBS, pH 7.4, for 10 min at 25 °C and then incubated with a rabbit polyclonal anti-β-catenin antibody (H-102, sc-7199, Santa Cruz, Dallas, TX, USA) diluted 1:200 in PBS and a goat anti-rabbit IgG (H&L), DyLight 594 conjugate, (ImmunoReagents, Raleigh, NC, USA) (diluted 1:500 in PBS), for 1 h and 45 min, respectively.
Unless otherwise stated, all of the experimental data are shown as mean ± standard deviation (SD) of at least three replications . Statistical analyses of data were performed using the Student’s t-test or two-way ANOVA, followed by the Tukey–Kramer multiple comparison test, to evaluate significant differences between a pair of means. For dose-response data, half maximal effective concentrations (EC50) were calculated using nonlinear regression analysis with Prism software 6.0 (GraphPad, GraphPad Software, San Diego, CA, USA, www.graphpad.com). EC50 are indicated as mean ± standard error mean (SEM). All data were analyzed using the two-tailed Student’s t-test and p < 0.05 indicated a statistically significant result.
The total (flesh and peel) polyphenolic content in AAE and LAE prepared for this study was determined by HPLC-DAD analysis and is reported in Table 1. AAE and LAE presented a qualitatively similar polyphenolic repertoire.
They contained a similar amount of chlorogenic acid, the most abundant hydroxycinnamic acid in apples, as well as of the flavan-3-ols, (+) catechin and (–) epicatechin. The quercetin-glycoside, rutin and the phloretin–glycoside, phloridzin, were more abundant in AAE than in LAE. The latter, on the contrary, contained higher amounts of procyanidin B2 and isoquercetin [24,26]. The aglycones, quercetin and phloretin were absent in both the extracts.
The activity of the apple extracts on WNT/β-catenin signaling was assayed in a reconstituted recombinant system. We used, as a biological platform, human embryonic HEK293 cells, transiently expressing both the WNT receptor Frizzled 4 (FZD4)  and a WNT pathway reporter DNA construct. Three different WNT reporter constructs were used. The first, hereinafter referred to as TCF-wt GFP, presents the coding sequence of GFP under the control of an optimized WNT pathway responsive promoter. In the second, hereinafter referred to as TCF-mut GFP, the WNT responsive promoter was mutagenized to become unresponsive to WNT (see methods for details). Finally, a third reporter construct (cmv GFP) presents the coding sequence of GFP under the control of a constitutive cmv promoter. The TCF-mut GFP and cmv GFP constructs were here considered as negative controls, and used to monitor WNT unrelated change in GFP expression.
The FZD agonist, WNT5A, induced GFP expression in HEK293 cells, transiently transfected with TCF-wt GFP (Figure S1). On the contrary, WNT5A did not affect GFP expression in cells transfected either with TCF-mut GFP or with cmv GFP (Figure S1), confirming the specificity of the platform. At the endogenous level, HEK293 cells express several other FZD receptors. However, differently from FZD4, these did not respond to WNT5A stimulation. As shown in Figure S1, in the absence of FZD4, WNT5A stimulation does not influence GFP expression in HEK293.
WNT5A has been shown to activate both the WNT/β-catenin pathway as well as one of the “non-canonical” branches of WNT signaling, the WNT/Ca2+ pathway . In our biological system, WNT5A increased GFP expression, mainly as a consequence of WNT/β-catenin pathway activation.
Inhibitors of Nuclear Factor of Activated T-cells (NFAT) and Protein Kinase C (PKC) (both key elements of the WNT/Ca2+ pathway) did not affect GFP expression induced by WNT5A (Figure S1). The combination of WNT5A and a recombinantly expressed FZD4 allowed us a clear interpretation of the effect of apple extracts on the WNT/β-catenin signaling pathway.
AAE and LAE both worked efficiently as WNT inhibitors and reduced WNT activity elicited by WNT5A. The EC50 of WNT pathway inhibition were 140 ± 16 mg/L and 330 ± 23 mg/L for AAE and LAE, respectively (Figure 1A,B). AAE and LAE did not affect GFP expression in cells transfected either with TCF-mut GFP or with cmv GFP (Figure S2), confirming that the two extracts affect the WNT/β-catenin pathway.
The WNT inhibitory activity of both the extracts mainly depends on their polyphenolic content. Compared to total fresh fruit extracts, polyphenolic enriched fractions of AAE and LAE, (hereinafter indicated as PEF(AAE) and PEF(LAE)) (Table 1) were associated with increased WNT inhibitory activity (2.1 ± 0.3 mg/L and 4.1 ± 0.2 mg/L for PEF(AAE) and PEF(LAE), respectively) (Figure 1C,D). The WNT inhibitory activity of both full extracts and polyphenolic fractions cannot be ascribed to their toxicity, which occurs at dilutions higher than 5.0 g/L (Figure S2).
In an attempt to identify which of the polyphenols contained in AAE and LAE were mostly contributing to the WNT inhibitory activity of the apple extracts, we tested them singularly, as pure molecules (Figure 2 and Table 2). HPLC grade, pure epicatechin and catechin both showed very weak WNT5A inhibitory activities. Chlorogenic acid had a WNT inhibitory activity of 3.4 ± 0.2 μM. Rutin and isoquercetin inhibited WNT5A with EC50 of 1.8 ± 0.1 μM and 3.1 ± 0.4 μM, respectively. Phloridzin and procyanidin B2 showed EC50 of 12.9 ± 0.5 μM and 1.4 ± 0.3 μM, respectively. Considering their low abundance in both the apple extracts, none of the abovementioned molecules would reach effective concentrations in AAE and LAE solutions diluted at their EC50 for WNT inhibition (Table 2). Thus, while polyphenols surely contribute to the WNT inhibitory activityof the apple extracts, none of the polyphenols by themselves can account for the full activity of AAE and LAE, which seem to require, on the contrary, the presence of the whole polyphenolic fraction.
We thus moved to identifying the WNT pathway branches inhibited by AAE and LAE. This is very important, especially when searching for therapeutic agents to use for FAP patients. Since APC is a midstream component of the WNT pathway, its mutations make the manipulation of most of the upstream signaling components therapeutically ineffective. To be active in FAP patients, WNT inhibitors should act either downstream to APC or on “non-canonical” WNT pathway branches. One of the most active non-canonical branches positively contributing to WNT signaling is the one involving the EGF Receptor (EGFR) [34,35]. Once activated, the EGFR pathway bypasses APC and leads, via AKT, to β-catenin activation.
We thus challenged AAE and LAE to compete with LiCl and EGF, two inducers of the WNT pathway, both acting downstream to APC. LiCl binds directly to GSK-3β and inhibits the β-catenin destruction complex. In contrast, EGF activates the EGFR pathway, that, via AKT, promotes β-catenin detachment from the Plasma Membrane and its nuclear translocation. In our biological system, both LiCl and EGF induced, in a dose-response manner, GFP expression in HEK293 transfected with TCF-wt GFP (Figure 3A–C). On the contrary, they both did not have an effect on cells transfected either with TCF-mut GFP or with cmv GFP (Figure 3A–C).
AAE and LAE failed to inhibit activation of the WNT pathway induced by 15 and 30 mM LiCl. However, they both reduced WNT pathway activity induced by 5 and 10 mM LiCl (the results for LAE are depicted in Figure 3B). Moreover, at all the tested concentrations, the extract abolished the WNT stimulatory activity of EGF  (Figure 3D). These results prove that the apple extracts inhibit WNT pathway activation induced by LiCl and EGF and are thus suitable WNT inhibitors for FAP cells carrying APC mutations.
The suitability of LAE and AAE for APC treatment was further proved in vitro, by testing the WNT inhibitory activity of AAE and LAE on CaCo-2 cells. This colon cancer cell line presents a mutation in the APC gene and is commonly used as in vitro cell culture prototype for FAP cells [36,37]. Despite presenting a mutation in APC, CaCo-2 cells are heterogeneous in regard to the WNT pathway activity. This is due to the strong adhesion established among neighbor cells. Cadherins sequester β-catenin at the plasma membrane of the cells, avoiding its translocation to the nucleus (Figure S3). CaCo-2 cells were transiently transfected with TCF-wt GFP (Figure 4A). Thanks to the GFP reporter construct, the small percentage of WNT active cells can be easily followed (Figure 4A). Upon treatment with AAE or LAE (400 mg/L, 48 h), GFP expression decreased in CaCo-2 cells (Figure 4A,B), indicating that the extracts efficiently inhibited the WNT pathway in these cells. Similar to what we measured in HEK293 cells, the extract affected the viability of the cells at dilutions higher than 5.0 g/L, (Figure 4B).
Finally, AAE and LAE were tested in an ex vivo system of FAP cells. Human colon biopsies were cultured in vitro soon after their resection from FAP patients (Figure 5). In unsupplemented media, these ex vivo samples survived and duplicated for up to two days (Figure 5A), and then underwent growth arrest. Treatment with AAE or LAE resulted in a decreased proliferation rate and survival of the ex vivo cultures (Figure 5A–C). The extracts arrested proliferation and induced cell death at dilutions of 400 mg/L and 5 g/L, respectively.
Food-grade manufacturing of fruit extracts can often affect patterns and structures of polyphenols. This is because extraction procedures for alimentary purposes only allow water and ethanol as solvents. Thus, the industry makes use of high temperatures and harsher conditions to increase the yield of extraction. We here tested the WNT inhibitory activity of apple extracts obtained from industrial-scale food-grade preparation of LAE (hereinafter referred as IndLAE). IndLAE presents a WNT inhibitory activity increase compared to LAE (EC50 of WNT pathway inhibition were of 47.4 ± 0.9 mg/L) (Figure 6A). A HPLC-DAD analysis of the flavonoid content of the IndLAE did not reveal major changes in the number of polyphenols compared to AAE and LAE (Table 3). However, we realized the presence of a discrete amount of quercetin, a molecule that was absent in the apple extracts, which probably arose from the conversion of quercetin glycosides into their aglycone form. Tested in our WNT inhibitory assay and as already demonstrated [38,39], quercetin had a strong inhibitory activity on the WNT pathway (EC50 at 110 ± 5 nM, Figure 6B) compared to the other polyphenols. This suggests that the molecule may contribute to the increased WNT inhibitory activity of the industrial extract.
To achieve WNT inhibitory activity in the colon, apple polyphenolic must be bio-accessible, i.e., they should be extracted from the food matrix, resist to GI-digestion and reach the colon-rectal section of the intestine. However, GI digestion may affect substantially native apple polyphenolic patterns and concentrations as well as induce drastic structural changes of the food constituents . During GI digestion, polyphenols may be further degraded  or hydrolyzed, deglycosylated or cleaved by esterases . To measure the bio-accessibility of the WNT inhibitory pool of apple polyphenol, we subjected apple extracts to in vitro simulated digestion . Upon digestion, AAE and LAE (hereinafter referred to as digAAE and digLAE) drastically lost their WNT inhibitory activity (Figure 7A,B). Results of the HPLC-DAD analysis of the polyphenolic contents of digAAE and digLAE are reported in Table 4. As expected, in vitro digestion decreased the overall polyphenolic content of around 40–50%. For both cultivars, digestion converted procyanidins into monomeric catechins, while total amounts of chlorogenic acid, rutin, epicatechin and isoquercetin were drastically reduced. Interestingly, GI digestion reduced the content of phloridzin in AAE but, not in LAE, where the molecule was almost completely resistant to GI. These results indicate that, most likely, the polyphenols ingested by consumption of fresh fruit or fresh fruit extract, will not reach the colon-rectal segment of the intestinal tract and strongly points towards the encapsulation of the extract in gastro-resistant tablets as an essential requirement to preserve apple extract WNT inhibitory activity.
Polyphenol consumption has been related to several health beneficial effects, such as reduced overall mortality , incidence of cancer  and cardiovascular diseases [12,13,20,44]. The diet is the principal human source of polyphenolic compounds. Polyphenol-rich foods include fruits, vegetables, whole grains, nuts and olive oil.
We here showed that apple extracts from both Annurca (AAE) and Limoncella (LAE) are endowed with inhibitory activity toward WNT/β-catenin signaling, an intracellular pathway involved in many forms of cancer. Moreover, we showed that both the extracts are potentially suitable for the treatment of FAP, a WNT related disease. In this syndrome, a mutation in the protein APC, leads to hyperactivation of the WNT/β-catenin signaling pathway and, in turn, to uncontrolled intestinal cell proliferation and a high risk for the formation of adenocarcinomas. We showed that both AAE and LAE are able to inhibit WNT signaling in cells carrying APC mutations. In both in vitro cultures of cells as well as in ex vivo biopsies of FAP patients, AAE and LAE blocked the proliferation and duplication rates of colon-rectal cancer cells.
AAE and LAE WNT inhibitory activity can be partially ascribed to their polyphenolic content. However, none of the major constituents of their polyphenolic fractions, tested as pure molecules, exerted strong WNT inhibitory activities, suggesting the importance of the whole pool of polyphenols for the activity of the extracts. WNT pathway inhibitory activity has been described for many individual polyphenols. Epigallocatechin gallate (EGCG) , isoquercetin , anthocyanins , theaflavin , ellagic acid derivatives , caffeoylquinic acids  and polymeric polyphenols  have all been shown to act as WNT inhibitors in many in vitro cultures of cancer cells. Some of them, like EGCG and ellagic acid, are undetectable in AAE and LAE . We cannot exclude that these could indeed account, alone, for the entire WNT inhibitory activity of the extracts in which they are contained. However, regarding the polyphenols we detected in AAE and LAE, our results are in line with previous reports describing, for these compounds, EC50 for WNT pathway inhibition in the micromolar range [35,52,53]. According to this and other studies , upon consumption of apples at consumer-relevant concentrations [55,56,57], none of the polyphenols contained in AAE and LAE (even assuming a full bioavailability) would reach active concentrations for WNT pathway inhibition in the colon-rectal segment of the intestine. This is in line with epidemiologic studies that, more and more, show that supplementation with mixtures of bioactive compounds more than with single components, may be effective in exerting biological activity [10,44,58,59,60].
Our preliminary results suggest that the WNT inhibitory activity of AAE and LAE can be ascribed either to the antioxidant activity of the entire polyphenolic mixture or to the effects that the latter may exert on its own components, protecting them from detrimental chemical modifications occurring in physiological environments.
We here showed that food-grade large-scale manufacturing alters the flavonoid composition of LAE, drastically increasing the WNT inhibitory activity of the extract. This could be ascribed to the presence of quercetin, a potent β-catenin inhibitor, absent in the original extract, which probably originated from the conversion of quercetin-glycosides into their aglycone form. This result should encourage researchers to test the activity of the extract after industrial manufacturing. The latter drastically alters the composition of the extract, even if this event, as we have here shown, does not always have to be detrimental to the properties of the extract.
We finally showed that both LAE and AAE lose activity upon in vitro simulated GI digestion as a result of a severe loss of polyphenols. This strongly points towards encapsulation in gastro-resistant tablets (for example enteric coatings) as an essential requirement to preserve apple extract WNT inhibitory activity in the colon-rectal section of the intestinal tract.
We thank Fabrizia Guerra for the technical support This work was financed by A.I.R.C., Associazione Italiana per la Ricerca sul Cancro (MFAG 17651 to Mariano Stornaiuolo).
The following are available online at http://www.mdpi.com/2072-6643/9/11/1262/s1. Figure S1: Description of the biological platform used to measure the activity of canonical WNT/β-catenin signaling in HEK293 cells, Figure S2: AAE and LAE inhibit WNT/β-catenin signaling in HEK293 cells, Figure S3: WNT/β-catenin pathway activity in CaCo-2 cells.
G.R., S.B., N.B. conducted all the biological experiments. M.M. and G.C.T. performed the fruit extraction and the characterization of the polyphenols. G.B.R. performed the resection of biopsies. M.S. and E.N. designed the experiments and wrote the paper.
The authors declare no conflict of interest.